错配修复基因hM SH2表达与膀胱移行细胞癌预后关系的研究

错配修复基因hM SH2表达与膀胱移行细胞癌预后关系的研
究
唐松喜;曹林升;周辉良;薛学义;林曦;罗义麒
【期刊名称】《福建医科大学学报》
【年(卷),期】2014(000)003
【摘要】目的：探讨错配修复基因hMSH2在膀胱移行细胞癌中的表达情况与肿
瘤预后的关系。

方法回顾性研究101例膀胱移行细胞癌患者的临床资料，采用免
疫组织化学法检测错配修复基因hMSH2的表达情况，通过门诊复查、书信或电
话联系方式对患者进行随访，随访12～72月，平均49月。

数据分析采用SPSS 21．0统计软件，生存分析应用Kaplan-M eier法，生存率比较采用Log-rank
检验，多因素分析采用Cox比例风险回归模型。

结果31例（31/101，30．7％）浸润性膀胱移行细胞癌患者中，22例hMSH2为（＋）表达，9例（9/101，8．9％）完全（-）表达；70例（70/101，69．3％）浅表性膀胱移行细胞癌为（触或处）表达。

随访结束时共56例复发，总复发率为55．45％。

单因素分析
发现，hMSH2低表达组平均无复发生存时间（57．20月）较高表达组（40．08月）长（P＜0．05）。

而膀胱移行细胞癌的TNM分期、组织学分级、淋巴结转
移与肿瘤复发亦密切相关（P＜0．05）；Cox比例风险模型多因素分析发现，仅TNM 分期及 hMSH2表达情况进入COX回归模型。

结论错配修复基因hMSH2
表达可能是膀胱移行细胞癌独立预后指标，与肿瘤复发紧密相关，hMSH2低表达组与相同分期的高表达组比较，复发可能性小。

%Objective To investigate the expression patterns of hMSH2 in human bladder transi-tional cell carcinoma and to assess the correlation of hMSH 2 protein to prognosis of
the patients . Meth-ods 101 bladder cancer patients at the First Affiliated Hospital of Fujian Medical University between 1999 to 2012 were investigated retrospectively ,we examined the expression patterns of hMSH2 by immunohis-tochemical technique ,followed the patients for a median time of 49 months(range 12~72 months) by out-patient
review ,mail ,or telephone . The survival rate was calculated by the Kaplan-Meier method ,the log-rank test and Cox's proportional hazards regression model using SPSS 21 .0 . Results Staining inten-sity of hMSH2 was as follows :weak staining in 22/101(21 .8% ) ,negative in 9/101 (8 .9% ) samples ,mod-erate or strong staining in 70/101 (69 .3% )
samples .56/101(55 .45% ) was found recurrence when the fol-low-up ended . Univariate survival analysis showed the average recurrence-free survival of patients whose tumous with reduced and preserved for hMSH2 was 40 .08 and 57 .20 months ,respectively ,with the difference being statistically significant in univariate analysis (χ2 =5 .798 ,
P=0 .016) ,indicated that prog-nosis of patients with TCC was significantly corrected with pathological stage ,histological grade ,lymph code metastasis ,as well as expression of hMSH2 (P<0 .05) . Cox proportional hazards model multivari-ate survival analysis showed that TNM stage and expression of hMSH 2 can be independent indicator for re-lapse of TCC . Conclusion hMSH2 expression may have a potential role as prognostic indicator ,reduced hMSH2 expression is associated with tumors of advanced stage and grade ,a favorable clinical outcome ap-pears present
when compared to those similar staged tumors with normal hMSH 2 expression .
【总页数】5页(P164-168)
【作者】唐松喜;曹林升;周辉良;薛学义;林曦;罗义麒
【作者单位】福建医科大学附属第一医院泌尿外科，福州 350005;福建医科大学附属第一医院泌尿外科，福州 350005;福建医科大学附属第一医院泌尿外科，福州 350005;福建医科大学附属第一医院泌尿外科，福州 350005;福建医科大学附属第一医院泌尿外科，福州 350005;福建医科大学附属第一医院泌尿外科，福州350005
【正文语种】中文
【中图分类】R737.14;R342.3;R730.2;R737.140.22;R977
【相关文献】
1.散发性胆囊癌nm23-H1基因遗传不稳定性与错配修复基因hMLH1和hMSH2蛋白表达的研究 [J], 张国强;张永奎;卢海英;李继承
2.膀胱移行细胞癌中DNA错配修复基因hMLH1、hMSH2和hMSH3启动子区甲基化状态研究 [J], 张志华;郭柏鸿;车团结;史葆光;郭利君;李元;陈一戎
3.错配修复基因hMSH6在胃癌中表达特点的研究 [J], 李雅楠;李梅;刘志敏;刘丽娜;王朝晖;吕申
4.错配修复基因hMSH2在膀胱移行细胞癌中的表达及意义 [J], 贾招辉;窦中岭;刘辉
5.错配修复基因hMLH1、hMSH2、hMSH6和hPMS2在左、右半结肠癌表达差异研究 [J], 王磊;张宁妹;张晓莉;罗廷燕;杨泽明;李海
因版权原因，仅展示原文概要，查看原文内容请购买。